About Sixfold Bioscience
Sixfold Bioscience is a company based in London (United Kingdom) founded in 2017.. Sixfold Bioscience has raised $4.59 million across 7 funding rounds from investors including European Union, Cantos Ventures and Y Combinator. The company has 16 employees as of December 31, 2021. Sixfold Bioscience offers products and services including Mergo Platform. Sixfold Bioscience operates in a competitive market with competitors including Insulet, Lyra Therapeutics, Candel Therapeutics, StrideBio and TriSalus Life Sciences, among others.
- Headquarter London, United Kingdom
- Employees 16 as on 31 Dec, 2021
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Sixfold Bioscience Inc.
- Date of Incorporation 08 Oct, 2018
- Jurisdiction WALNUT, CALIFORNIA 91789, UNITED STATES
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$4.59 M (USD)
in 7 rounds
-
Latest Funding Round
$2.2 M (USD), Seed
Dec 02, 2021
-
Investors
European Union
& 4 more
-
Employee Count
16
as on Dec 31, 2021
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Sixfold Bioscience
Sixfold Bioscience offers a comprehensive portfolio of products and services, including Mergo Platform. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
AI-enhanced platform for RNA therapy delivery solutions.
Unlock access to complete
Unlock access to complete
Funding Insights of Sixfold Bioscience
Sixfold Bioscience has successfully raised a total of $4.59M across 7 strategic funding rounds. The most recent funding activity was a Seed round of $2.2 million completed in December 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 7
- Last Round Seed — $2.2M
-
First Round
First Round
(21 Mar 2018)
- Investors Count 5
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Dec, 2021 | Amount | Seed - Sixfold Bioscience | Valuation | Cantos Ventures , Y Combinator |
|
| Apr, 2021 | Amount | Grant - Sixfold Bioscience | Valuation |
investors |
|
| Feb, 2021 | Amount | Seed - Sixfold Bioscience | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Sixfold Bioscience
Sixfold Bioscience has secured backing from 5 investors, including venture fund and institutional investors. Prominent investors backing the company include European Union, Cantos Ventures and Y Combinator. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Seed stage tech-focused VC firm investing primarily in the US
|
Founded Year | Domain | Location | |
|
Early-stage startups are accelerated via funding and educational programs.
|
Founded Year | Domain | Location | |
|
Early-stage AI startups are funded and supported by Pi Campus.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Sixfold Bioscience
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Sixfold Bioscience
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Sixfold Bioscience Comparisons
Competitors of Sixfold Bioscience
Sixfold Bioscience operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Insulet, Lyra Therapeutics, Candel Therapeutics, StrideBio and TriSalus Life Sciences, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Wearable insulin infusion systems are developed for diabetes patients.
|
|
| domain | founded_year | HQ Location |
Small molecule therapeutics for ENT diseases are developed.
|
|
| domain | founded_year | HQ Location |
Viral immunotherapies are developed for cancer treatment.
|
|
| domain | founded_year | HQ Location |
AAV-based gene therapies for rare diseases are developed.
|
|
| domain | founded_year | HQ Location |
Developer of drug delivery devices to treat cancers
|
|
| domain | founded_year | HQ Location |
Genetic medicines are delivered using polymer nanoparticle platforms.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Sixfold Bioscience
Frequently Asked Questions about Sixfold Bioscience
When was Sixfold Bioscience founded?
Sixfold Bioscience was founded in 2017 and raised its 1st funding round 1 year after it was founded.
Where is Sixfold Bioscience located?
Sixfold Bioscience is headquartered in London, United Kingdom. It is registered at London, England, United Kingdom.
Is Sixfold Bioscience a funded company?
Sixfold Bioscience is a funded company, having raised a total of $4.59M across 7 funding rounds to date. The company's 1st funding round was a Seed of $2.27M, raised on Mar 21, 2018.
How many employees does Sixfold Bioscience have?
As of Dec 31, 2021, the latest employee count at Sixfold Bioscience is 16.
What does Sixfold Bioscience do?
Sixfold Bioscience was founded in 2017 in London, United Kingdom. Operations are centered in the biotechnology sector, where oligonucleotide delivery systems are developed. The Mergo platform is employed to target gene therapy molecules to diseased cells. In vivo delivery methods for RNA therapeutics are supported by this technology, enabling precise administration in therapeutic applications.
Who are the top competitors of Sixfold Bioscience?
Sixfold Bioscience's top competitors include Insulet, Lyra Therapeutics and TriSalus Life Sciences.
What products or services does Sixfold Bioscience offer?
Sixfold Bioscience offers Mergo Platform.
Who are Sixfold Bioscience's investors?
Sixfold Bioscience has 5 investors. Key investors include European Union, Cantos Ventures, Y Combinator, Pi Campus, and Lombardstreet Ventures.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.